STEPHENY SUMRALL: Open Payments
NPI 1386046704 · LAFAYETTE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$212 in 9 payments from 5 companies in 2025. Trend: 2023 $400 · 2024 $231 · 2025 $212
Food & beverage: $212
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $95 |
| Novo Nordisk Inc | 3 | $51 |
| Neurocrine BioSciences, Inc. | 2 | $37 |
| Exact Sciences Corporation | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: General - Therapies, INGREZZA, ACCOLADE SR, Wegovy, Cologuard Collection Kit, XIFAXAN, Ozempic.
Industry payments across LA — which companies pay providers there.
